Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis: an application to basiliximab in renal transplantation.
- 1 January 1999
- journal article
- clinical trial
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 27 (2) , 213-230
- https://doi.org/10.1023/a:1020658023774
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1Transplantation, 1997
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- COMPARISON OF POPULATION PHARMACOKINETIC MODELING METHODS USING SIMULATED DATA: RESULTS FROM THE POPULATION MODELING WORKGROUPStatistics in Medicine, 1997
- The Effect of Variance Function Estimation on Nonlinear Calibration Inference in Immunoassay DataBiometrics, 1996
- Multiple estimation of concentrations in immunoassay using logistic modelsJournal of Immunological Methods, 1995
- PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1995
- Assays for recombinant proteins: A problem in non‐linear calibrationStatistics in Medicine, 1994
- EARLY VERSUS LATE ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1993
- Alternative Approaches to Estimation of Population Pharmacokinetic Parameters: Comparison with the Nonlinear Mixed-Effect ModelDrug Metabolism Reviews, 1984